Young age - an unusual finding of Hürthle cell carcinoma

Laura Claudia Teodoriu, Delia Gabriela Ciobanu-Apostol, Alexandru Grigorovici, Cristina Preda


Hürthle cell carcinoma is a rare thyroid neoplasm which originates from the follicular epithelium of the thyroid gland and is considered a true rarity in young patients. A 30 year-old woman was admitted to our department with palpable anterior cervical mass due to enlarged thyroid. The ultrasound revealed a large thyroid nodule with central hypoechogenicity, peripheral hyperechogenicity and positive Doppler signal. The patient had no distinguishable lateral cervical lymphadenopathy. The TI-RADS calculation (thyroid image reporting data system) classified the nodule as TR4 (4 points), which indicated a fine needle aspiration biopsy (FNAB), declined by the patient. Total thyroidectomy was performed and the histological findings associated with immunohistochemical study revealed the diagnosis of Hürthle cell carcinoma with capsular and vascular invasion. Because the microscopic vascular invasion was < 4 foci the patient was classified as low-risk group. Even so, due to the young age she was referred to radioactive iodine therapy for completion of curative treatment. This case illustrates the difficulties in the management of thyroid nodules with suspicious features on ultrasound, in the absence of FNAB exploration, and the unusual presence of Hürthle cell carcinoma in a young age patient, knowing the 6th decade is the average age for this rare type of thyroid neoplasm.


thyroid neoplasm; Hürthle cell carcinoma; thyroid cancer; young patient; aggressive treatment

Full Text:



Ahmadi S, Stang M, Jiang X, Sosa JA. Hürthle cell carcinoma: current perspectives. Onco Targets Ther 2016; (9):6873-6884.

Donatini G, Beaulieu A, Castagnet M, Kraimps JL, Levillain P, Fromont G. Thyroid Hürthle cell tumors: research of potential markers of malignancy. J Endocrinol Invest 2016; 39(2):153-158.

Oluic B, Paunovic I, Loncar Z, et al. Survival and prognostic factors for survival, cancer specific survival and disease free interval in 239 patients with Hürthle cell carcinoma: a single center experience. BMC Cancer 2017; 17(1):371.

Li P, Liu P, Zhang H. Ultrasonic diagnosis for thyroid Hürthle cell tumor. Cancer Biomark 2017; 20(3):235-240.

Jillard CL, Youngwirth L, Scheri RP, Roman S, Sosa JA. Radioactive iodine treatment is associated with improved survival for patients with Hürthle cell carcinoma. Thyroid 2016; 26(7):959-964.

Xiong Y, Zhao Q, Li Z, et al. Propensity score matching analysis of the prognosis for the rare oxyphilic subtype of thyroid cancer (Hürthle cell carcinoma). Oncotarget 2017; 8(60):101362-101371.

Tai P, Korzeniowski M, Sadikov E, et al. Issues in managing Hürthle cell carcinoma of thyroid: a case report. Cureus 2017; 9(4):e1167.


Copyright (c) 2019 Laura Claudia Teodoriu, Delia Gabriela Ciobanu-Apostol, Alexandru Grigorovici, Cristina Preda

Creative Commons License
Archive of Clinical Cases is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.


ISSN: 2360-6975